Boehringer and Click's CT-155 plus antipsychotics significantly reduced negative symptoms associated with schizophrenia in a Phase III trial ...

Q2 2025 Earnings Call Transcript August 6, 2025 Fortrea Holdings Inc. beats earnings expectations. Reported EPS is $0.19, ...

DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which ...

Objectives Athletes have been found to experience a similar prevalence of mental health issues to non-athletes. However, they are subjected to a greater array of barriers to help-seeking for mental ...

Researchers at Harvard Medical School have identified a potential breakthrough in understanding Alzheimer's disease after ...

The "Pneumococcal Disease - Pipeline Insight, 2025" report offers in-depth analysis of over 20 drugs and 18 companies in the Pneumococcal Disease pipeline, covering clinical and nonclinical stages.

Research and development expenses grew 16.7% year-over-year in Q2 2025, while net loss (GAAP) widened to $26.8 million. No revenue was reported, and Immunic requires additional funding within twelve ...

In the Phase III TRIUMpH program, tegoprazan met primary endpoints and outperformed lansoprazole in maintaining healing of ...

The team of Talwar and Malinowski, better known as “Shark Docs” was crowned kings of the sea and received the ultimate prize: ...

Discover how to become a doctor in India with this complete step-by-step guide. Get to know about NEET, MBBS eligibility, top ...

Pfizer is the closest company to producing a Lyme disease vaccine. Experts are concerned that vaccine skepticism could stand in its way.

Within hours of Ofcom enforcing the new law last week, Gaza and Ukraine content was being blocked, while pickup artist ...